A staggering 64% of adults in England are classed as either overweight or obese according to the most recent NHS figures. And ...

A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia. The drug, tirzepatide, is ...

In a reversal, the FDA is reconsidering its decision to end the shortage status of tirzepatide, after a recent lawsuit and intense public pressure, The Washington Post reported Oct. 21.

Mounjaro and Zepbound are now out of shortage. This should be good news—but because so many patients are taking compounded ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

The U.S. Food and Drug Administration (FDA) is rethinking its decision to remove popular weight-loss and diabetes drugs from ...

The weight-loss drugs are linked with reduced rates of excess drinking and opioid overdoses, suggesting they may tamp down ...

The British government announced a multimillion dollar pharmaceutical partnership with Eli Lilly, including a trial that will ...

Here are insights into Tori Spelling’s weight loss journey and how the actress toned herself down. From medications to diet ...

Martin received a prescription for a compounded drug containing tirzepatide − the active ingredient also found in Mounjaro and Zepbound. Martin has lost about 80 pounds since and continues to ...

The reconsideration follows an Oct. 11 lawsuit that prompted U.S. District Judge Mark Pittman to temporarily halt legal proceedings to give the FDA time to reassess its ruling.

Both Wegovy and Mounjaro are given as weekly injections via pre-filled pens that can be self-administered into the upper arm, ...